Funding · Company
Lycia Therapeutics, Inc.
South San Francisco, CABiotech & Pharma
Lycia Therapeutics, Inc. of South San Francisco, CA has disclosed $252M across 3 Form D offerings filed with the SEC between Sep 16, 2021 and Jun 25, 2026.
$252M
Total disclosed
3
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersSouth San Francisco, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001806540Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →